Records 1 - 4
| Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer.
Molecular & cellular oncology 2020 7 (3): 1716618.
Douglas Jason K, Callahan Rose E, Hothem Zachary A, Cousineau Craig S, Kawak Samer, Thibodeau Bryan J, Bergeron Shelli, Li Wei, Peeples Claire E, Wasvary Harry
| Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
Journal of Cancer 2018 9 (6): 1067-1077.
Peng Jianhong, Ma Wenjuan, Zhou Zhongguo, Gu Yangkui, Lu Zhenhai, Zhang Rongxin, Pan Zhizho
| Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
Nutrition and cancer 2011 Nov 63 (8): 1226-34.
Slattery Martha L, Lundgreen Abbie, Herrick Jennifer S, Caan Bette J, Potter John D, Wolff Roger
| Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Carcinogenesis 2010 Sep 31 (9): 1604-11.
Slattery Martha L, Herrick Jennifer S, Lundgreen Abbie, Fitzpatrick Francis A, Curtin Karen, Wolff Roger